Functional Distinctions of Endometrial Cancer-Associated Mutations in the Fibroblast Growth Factor Receptor 2 Gene [PDF]
Functional analysis of somatic mutations in tumorigenesis facilitates the development and optimization of personalized therapy for cancer patients. The fibroblast growth factor receptor 2 (FGFR2) gene is frequently mutated in endometrial cancer (EC), but
Garima Dixit +4 more
doaj +2 more sources
Fibroblast growth factor 10 attenuates advanced liver fibrosis through hepatocyte fibroblast growth factor receptor 2 signalling [PDF]
Background Metabolic dysfunction–associated steatotic liver disease (MASLD) and advanced fibrotic stages are significant contributors to cirrhosis and liver‐related mortality, yet no therapies directly target fibrosis in the later stages of the disease ...
Xuanxin Yang +20 more
doaj +2 more sources
2H-pyrazolo[3,4-d]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitors [PDF]
Although FGFR2 is a well-validated oncogenic target, no selective FGFR2 inhibitors have been approved for clinical use. In this study, we report the discovery of 2H-pyrazolo[3,4-d]pyrimidin-4-amine derivative as novel, irreversible FGFR2 inhibitors.
Pinglian Wu +11 more
doaj +2 more sources
Role of Fibroblast Growth Factor Receptor 2 (FGFR2) in Corneal Stromal Thinning. [PDF]
To determine the role of fibroblast growth factor receptor 2 (FGFR2)-mediated signaling in keratocytes during corneal development, a keratocyte-specific FGFR2-knockout (named FGFR2cKO) mouse model was generated, and its phenotypic characteristics were determined.A FGFR2cKO mouse model was generated by the following method: FGFR2 flox mice were crossed ...
Joseph R +3 more
europepmc +3 more sources
Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer. [PDF]
Fibroblast growth factor receptor 2 (FGFR2) is a membrane-spanning tyrosine kinase that mediates signaling for FGFs. Recent studies detected various point mutations of FGFR2 in multiple types of cancers, including breast cancer, lung cancer, gastric cancer, uterine cancer and ovarian cancer, yet the casual relationship between these mutations and ...
Lei H, Deng CX.
europepmc +4 more sources
Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. [PDF]
BackgroundHepatocellular carcinoma (HCC) recurrence after liver resection depends upon the stage and histological grade of the tumor and the expression of certain biomarkers.
Baek Gyu Jun +11 more
doaj +2 more sources
The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor [PDF]
Background The fibroblast growth factor receptor (FGFR) interprets concentration gradients of FGF ligands and structural changes in the heparan sulfate (HS) co-receptor to generate different cellular responses.
Duchesne Laurence +3 more
doaj +3 more sources
Fibroblast growth factor receptor 2 (FGFR2) genetic polymorphisms contribute to fused roots in human molars. [PDF]
Fibroblast growth factors (FGFRs) signaling are required for human tooth development. Its dysregulation affects tooth formation and patients with FGFR2 mutations often present dental anomalies in the spectrum of the syndrome.
Sandra Regina Santos Meyfarth +9 more
doaj +2 more sources
The Role of Fibroblast Growth Factor Receptor 2 as A Prognostic Biomarker in Colorectal Adenocarcinoma. [PDF]
This study aimed to analyze the correlation between fibroblast growth factor receptor 2 (FGFR2) expression with the histopathological grade, tumor budding grade, lymphovascular invasion, and lymph node metastasis in colorectal adenocarcinoma.This study used a cross-sectional design. Immunohistochemistry was performed on one hundred slides from paraffin-
Rianti AM +5 more
europepmc +3 more sources
Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma. [PDF]
This review will cover the role of the fibroblast growth factor pathway in the pathogenesis, targeted therapy potential and prognostic value in patients with cholangiocarcinoma (CCA).Recent studies that have identified fibroblast growth factor receptor 2 (FGFR2) fusions, prognostic implications of FGFR2 fusions, treatment strategies that target FGFR2 ...
Borad MJ, Gores GJ, Roberts LR.
europepmc +4 more sources

